1019 |
Perspectives from PARTNER Trial |
Martin Bert Leon |
May. 12. 11 |
1018 |
Evolving Technologies to Improve Outcomes of TAVI |
Augusto D. Pichard |
May. 12. 11 |
1017 |
Incidence and Treatment of Procedural Complications |
Eberhard Grube |
May. 12. 11 |
1016 |
Endovascular Intervention |
John R. Laird |
May. 12. 11 |
1015 |
Valvular Heart Disease & Adult Congenital Intervention |
Augusto D. Pichard |
May. 12. 11 |
1014 |
Coronary Intervention |
David R. Holmes |
May. 12. 11 |
1013 |
Interventional Pharmacology |
Matthew Price |
May. 12. 11 |
1012 |
[Evolving Genotyping and Platelet Function Test: Personalized Antiplatelet Therapy Possible in Real Practice?] Cons |
Guillaume Pare |
May. 12. 11 |
1011 |
[Evolving Genotyping and Platelet Function Test: Personalized Antiplatelet Therapy Possible in Real Practice?] Pros |
Marc S. Sabatine |
May. 12. 11 |
1010 |
PFO Closure: Where We Are Going to after CLOSURE Study? |
Issam D. Moussa |
May. 12. 11 |